These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12559689)

  • 1. Mechanistic and toxicokinetic data reducing uncertainty in risk assessment.
    Greim H
    Toxicol Lett; 2003 Feb; 138(1-2):1-8. PubMed ID: 12559689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of covalent binding in risk assessment.
    Greim H
    Adv Exp Med Biol; 2001; 500():715-22. PubMed ID: 11765018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide.
    Walker VE; Wu KY; Upton PB; Ranasinghe A; Scheller N; Cho MH; Vergnes JS; Skopek TR; Swenberg JA
    Carcinogenesis; 2000 Sep; 21(9):1661-9. PubMed ID: 10964097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiologically based toxicokinetic model for inhaled ethylene and ethylene oxide in mouse, rat, and human.
    Filser JG; Klein D
    Toxicol Lett; 2018 Apr; 286():54-79. PubMed ID: 28774830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A toxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung.
    Csanády GA; Kessler W; Hoffmann HD; Filser JG
    Toxicol Lett; 2003 Feb; 138(1-2):75-102. PubMed ID: 12559694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism, variability and risk assessment.
    Dorne JL
    Toxicology; 2010 Feb; 268(3):156-64. PubMed ID: 19932147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2-hydroxyethyl adducts with hemoglobin and DNA.
    Csanády GA; Denk B; Pütz C; Kreuzer PE; Kessler W; Baur C; Gargas ML; Filser JG
    Toxicol Appl Pharmacol; 2000 May; 165(1):1-26. PubMed ID: 10814549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Based on an analysis of mode of action, styrene-induced mouse lung tumors are not a human cancer concern.
    Cruzan G; Bus JS; Andersen ME; Carlson GP; Banton MI; Sarang SS; Waites R
    Regul Toxicol Pharmacol; 2018 Jun; 95():17-28. PubMed ID: 29496518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and disposition in toxicology. Example: carcinogenic risk estimate for ethylene.
    Bolt HM; Filser JG
    Arch Toxicol; 1987; 60(1-3):73-6. PubMed ID: 3619647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
    Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
    Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.
    Kirman CR; Sweeney LM; Meek ME; Gargas ML
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):345-67. PubMed ID: 14623485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research needs to improve risk assessment of fiber toxicity.
    Greim HA
    Mutat Res; 2004 Sep; 553(1-2):11-22. PubMed ID: 15288529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment.
    van Sittert NJ; Boogaard PJ; Natarajan AT; Tates AD; Ehrenberg LG; Törnqvist MA
    Mutat Res; 2000 Jan; 447(1):27-48. PubMed ID: 10686305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and existing data for a future physiological toxicokinetic model of ethylene and its metabolite ethylene oxide in mouse, rat, and human.
    Filser JG; Artati A; Li Q; Pütz C; Semder B; Klein D; Kessler W
    Chem Biol Interact; 2015 Nov; 241():76-86. PubMed ID: 25868680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.